DE60110564T2 - Rna polymerase mutanten mit erhöhter thermostabilität - Google Patents
Rna polymerase mutanten mit erhöhter thermostabilität Download PDFInfo
- Publication number
- DE60110564T2 DE60110564T2 DE60110564T DE60110564T DE60110564T2 DE 60110564 T2 DE60110564 T2 DE 60110564T2 DE 60110564 T DE60110564 T DE 60110564T DE 60110564 T DE60110564 T DE 60110564T DE 60110564 T2 DE60110564 T2 DE 60110564T2
- Authority
- DE
- Germany
- Prior art keywords
- rna polymerase
- mutant
- rna
- transcription
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 title claims abstract description 48
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 title claims abstract description 48
- 101710137500 T7 RNA polymerase Proteins 0.000 claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 7
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000001413 amino acids Chemical group 0.000 claims abstract description 6
- -1 proline amino acid Chemical class 0.000 claims abstract description 4
- 230000035772 mutation Effects 0.000 claims description 39
- 102000004190 Enzymes Human genes 0.000 claims description 38
- 108090000790 Enzymes Proteins 0.000 claims description 38
- 238000013518 transcription Methods 0.000 claims description 36
- 230000035897 transcription Effects 0.000 claims description 36
- 230000000694 effects Effects 0.000 claims description 32
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 22
- 230000003321 amplification Effects 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 150000007523 nucleic acids Chemical class 0.000 claims description 18
- 239000013598 vector Substances 0.000 claims description 18
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 7
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 4
- 102100034343 Integrase Human genes 0.000 claims 1
- 241001515965 unidentified phage Species 0.000 abstract description 22
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 22
- 238000000034 method Methods 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 21
- 239000013612 plasmid Substances 0.000 description 18
- 108091034117 Oligonucleotide Proteins 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 241000588724 Escherichia coli Species 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 238000003556 assay Methods 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000701867 Enterobacteria phage T7 Species 0.000 description 5
- 102000006382 Ribonucleases Human genes 0.000 description 5
- 108010083644 Ribonucleases Proteins 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 239000001166 ammonium sulphate Substances 0.000 description 5
- 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 5
- 229960005091 chloramphenicol Drugs 0.000 description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 102100031780 Endonuclease Human genes 0.000 description 4
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 229920002873 Polyethylenimine Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000713869 Moloney murine leukemia virus Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 101150055766 cat gene Proteins 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011901 isothermal amplification Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 241001136792 Alle Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001295925 Gegenes Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001562081 Ikeda Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 108010065868 RNA polymerase SP6 Proteins 0.000 description 1
- 108091028733 RNTP Proteins 0.000 description 1
- JQYMGXZJTCOARG-UHFFFAOYSA-N Reactive blue 2 Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC(S(O)(=O)=O)=C1 JQYMGXZJTCOARG-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200787 | 2000-03-07 | ||
| EP00200787 | 2000-03-07 | ||
| PCT/EP2001/002327 WO2001066705A1 (en) | 2000-03-07 | 2001-03-01 | Rna polymerase mutants with increased thermostability |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60110564D1 DE60110564D1 (en) | 2005-06-09 |
| DE60110564T2 true DE60110564T2 (de) | 2006-01-19 |
Family
ID=8171152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60110564T Expired - Lifetime DE60110564T2 (de) | 2000-03-07 | 2001-03-01 | Rna polymerase mutanten mit erhöhter thermostabilität |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7507567B2 (enExample) |
| EP (1) | EP1261696B1 (enExample) |
| JP (1) | JP4832694B2 (enExample) |
| AT (1) | ATE294855T1 (enExample) |
| AU (1) | AU2001237425A1 (enExample) |
| CA (1) | CA2400049C (enExample) |
| DE (1) | DE60110564T2 (enExample) |
| ES (1) | ES2242733T3 (enExample) |
| WO (1) | WO2001066705A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009136153A (ja) * | 2007-12-03 | 2009-06-25 | Tosoh Corp | 変異型ｒｎａポリメラーゼ |
| WO2009113718A1 (ja) * | 2008-03-11 | 2009-09-17 | 東ソー株式会社 | 機能改善したｒｎａポリメラーゼ変異体 |
| KR20110044753A (ko) * | 2008-08-08 | 2011-04-29 | 토소가부시키가이샤 | 기능 개선된 ｒｎａ 중합효소 변이체 |
| US9193959B2 (en) * | 2010-04-16 | 2015-11-24 | Roche Diagnostics Operations, Inc. | T7 RNA polymerase variants with enhanced thermostability |
| EP2611922A1 (en) | 2010-08-31 | 2013-07-10 | Greenlight Biosciences, Inc. | Methods for control of flux in metabolic pathways through protease manipulation |
| US9062292B2 (en) | 2010-09-13 | 2015-06-23 | Enzo Life Sciences Inc. | Mutant T7 polymerases |
| FR2981088B1 (fr) | 2011-10-06 | 2013-11-29 | Biomerieux Sa | Arn polymerases mutees |
| US9045740B2 (en) * | 2012-02-24 | 2015-06-02 | University Of Massachusetts | Modified T7-related RNA polymerases and methods of use thereof |
| EP3030671B1 (en) | 2013-08-05 | 2018-10-03 | Greenlight Biosciences, Inc. | Engineered proteins with a protease cleavage site |
| WO2015024017A2 (en) * | 2013-08-16 | 2015-02-19 | President And Fellows Of Harvard College | Rna polymerase, methods of purification and methods of use |
| EP3119873A4 (en) * | 2014-03-20 | 2018-01-03 | The Board of Regents of The University of Texas System | T7 rna polymerase variants with expanded substrate range and enhanced transcriptional yield |
| SG11201707370WA (en) | 2015-03-30 | 2017-10-30 | Greenlight Biosciences Inc | Cell-free production of ribonucleic acid |
| US20190017100A1 (en) * | 2015-07-01 | 2019-01-17 | Curevac Ag | Method for analysis of an rna molecule |
| EP3402881B1 (en) | 2016-01-13 | 2021-04-28 | New England Biolabs, Inc. | Thermostable variants of t7 rna polymerase |
| US10954541B2 (en) | 2016-04-06 | 2021-03-23 | Greenlight Biosciences, Inc. | Cell-free production of ribonucleic acid |
| US10034951B1 (en) | 2017-06-21 | 2018-07-31 | New England Biolabs, Inc. | Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity |
| JP7588391B2 (ja) | 2017-06-30 | 2024-11-22 | コデクシス， インコーポレイテッド | Ｔ７ ｒｎａポリメラーゼバリアント |
| CN111417724A (zh) | 2017-06-30 | 2020-07-14 | 科德克希思公司 | T7 rna聚合酶变体 |
| AU2018347405B2 (en) | 2017-10-11 | 2022-02-03 | Greenlight Biosciences, Inc. | Methods and compositions for nucleoside triphosphate and ribonucleic acid production |
| US20210180034A1 (en) * | 2018-04-10 | 2021-06-17 | Greenlight Biosciences, Inc. | T7 rna polymerase variants |
| AU2020283757A1 (en) * | 2019-05-24 | 2022-01-20 | Primrose Bio, Inc. | Methods and compositions for manufacturing polynucleotides |
| CN112980811B (zh) * | 2021-03-06 | 2022-02-25 | 苏州瀚源新酶生物科技有限公司 | Rna聚合酶突变体及其应用、重组载体及其制备方法和应用、重组工程菌及其应用 |
| EP4108770A1 (en) | 2021-06-24 | 2022-12-28 | Aptamimetics GmbH | Age-selex method for aptamer identification and use |
| WO2025127053A1 (ja) * | 2023-12-12 | 2025-06-19 | タカラバイオ株式会社 | Ｒｎａポリメラーゼ変異体とｒｎａ合成 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4952496A (en) * | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| CA1340807C (en) * | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| US5385834A (en) * | 1993-08-13 | 1995-01-31 | Georgia Tech Research Corporation | Mutant T7 RNA polymerase GP1(lys222) exhibiting altered promoter recognition |
| FR2761695B1 (fr) | 1997-04-04 | 1999-09-24 | Bio Merieux | Arn polymerase fonctionnant preferentiellement sur matrice d'arn, sa preparation et son utilisation |
| JP3172710B2 (ja) | 1997-07-07 | 2001-06-04 | 理化学研究所 | Ｒｎａポリメラーゼ |
| ATE266729T1 (de) * | 1998-12-11 | 2004-05-15 | Biomerieux Bv | Rna polymerase mutanten mit erhöhter stabilität |
| JP4399684B2 (ja) * | 1999-08-17 | 2010-01-20 | 東洋紡績株式会社 | 改良されたｒｎａポリメラーゼ |
-
2001
- 2001-03-01 CA CA2400049A patent/CA2400049C/en not_active Expired - Lifetime
- 2001-03-01 JP JP2001565862A patent/JP4832694B2/ja not_active Expired - Lifetime
- 2001-03-01 US US10/220,908 patent/US7507567B2/en not_active Expired - Lifetime
- 2001-03-01 EP EP01909810A patent/EP1261696B1/en not_active Expired - Lifetime
- 2001-03-01 DE DE60110564T patent/DE60110564T2/de not_active Expired - Lifetime
- 2001-03-01 AU AU2001237425A patent/AU2001237425A1/en not_active Abandoned
- 2001-03-01 WO PCT/EP2001/002327 patent/WO2001066705A1/en not_active Ceased
- 2001-03-01 AT AT01909810T patent/ATE294855T1/de active
- 2001-03-01 ES ES01909810T patent/ES2242733T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4832694B2 (ja) | 2011-12-07 |
| ES2242733T3 (es) | 2005-11-16 |
| US7507567B2 (en) | 2009-03-24 |
| CA2400049C (en) | 2010-10-05 |
| US20030175738A1 (en) | 2003-09-18 |
| JP2003525627A (ja) | 2003-09-02 |
| DE60110564D1 (en) | 2005-06-09 |
| EP1261696B1 (en) | 2005-05-04 |
| AU2001237425A1 (en) | 2001-09-17 |
| WO2001066705A1 (en) | 2001-09-13 |
| ATE294855T1 (de) | 2005-05-15 |
| EP1261696A1 (en) | 2002-12-04 |
| CA2400049A1 (en) | 2001-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60110564T2 (de) | Rna polymerase mutanten mit erhöhter thermostabilität | |
| DE69923180T2 (de) | Thermostabiles Enzym welches die Genauigkeit thermostabiler DNA Polymerasen erhöht - zur Verbesserung der Nucleinsäuresynthese und in vitro Amplifikation | |
| DE69838724T2 (de) | Polymerase-verbessernder faktor (pef)-enthaltende extrakte, pef proteinkomplexe, isoliertes pef protein und verfahren zur reinigung und identifizierung | |
| DE60034396T2 (de) | Reaktionsgemisch und Verfahren für RT-PCR mittels einer homopolymeren Nukleinsäure | |
| DE69131321T2 (de) | Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen | |
| DE69426400T2 (de) | Thermostable Nukleinsäure Polymerase | |
| DE69836779T2 (de) | Mutierte chimäre DNS-Polymerasen | |
| DE19953854C2 (de) | Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften | |
| DE69611102T2 (de) | Verstärkung der mutagenese von nukleinsäuren | |
| DE69133204T2 (de) | Gereinigtes thermostabiles nukleinsäure-polymeraseenzym aus thermotoga maritima | |
| DE69132477T2 (de) | Gereinigte thermostabile nukleinsäurepolymerase aus thermosipho africanus | |
| DE69519968T2 (de) | Rekombinierte thermostabile DNA-Polymerase von Archaebakterie | |
| DE69725076T2 (de) | Modifizierte thermostabile DNA Polymerase und eine DNA Polymerasezusammensetzung zur Amplifikation von Nukleinsäuren | |
| JP2003519488A (ja) | 活性部位に１又は複数の変異を有するｄｎａポリメラーゼ変異体 | |
| DE69527803T2 (de) | Aufgereinigte dna-polymerase von thermococcus barossii | |
| DE60214864T2 (de) | Verfahren zur herstellung von nukleinsäuren bestehend aus stochastisch kombinierten anteilen von ausgangsnukleinsäuren | |
| DE69917322T2 (de) | Rna polymerase mutanten mit erhöhter stabilität | |
| DE69233253T2 (de) | Verfahren zum Klonieren eines Pol-I-Typ DNS-Polymerase-Gens | |
| DE60317693T2 (de) | Methode und verwendung von thermostabilen rna-ligasen | |
| DE60029225T2 (de) | Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese | |
| EP1169438A1 (en) | Pcr-based cloning method | |
| DE69837535T2 (de) | RNS-abhängige RNS-Polymerase, die vorzugsweise an Hand einer RNA-Matrix funktioniert und ein Promoter-abhängiger Transkriptionsprozess, der diese RNS-abhängige RNS-Polymerase benutzt. | |
| EP1326964B1 (de) | THERMOSTABILE POLYMERASE AUS i THERMOCOCCUS PACIFICUS /i | |
| DE69832459T2 (de) | Modifizierte DNA Polymerase aus Corboxydothermus hydrogenoformans und deren Verwendung für gekoppelte reverse Transkription und Polymerase-Kettenreaktion | |
| EP1198571A2 (de) | Chimäre proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |